港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

生物医药B类股

618.706

+13.1722.18%

涨家数：23

跌家数：8

平家数：3

市盈率：- -

高：627.633

开：605.584

低：600.085

收：605.533

成交量：1.29亿

成交额：38.26亿

市值：3,831.01亿

流通市值：3,410.50亿

数据加载中...

创新药突然爆发，基金经理火线解读！多头猛攻，港股通创新药ETF（520880）大阳线拔地而起，放量摸高5.25%！

归创通桥(02190)10月31日耗资约118.74万港元回购5万股

迈博药业-B(02181)：张雁云已获指定为首席独立非执行董事

歌礼制药-B(01672)10月31日耗资约193.27万港元回购20万股

9个月干了过去3年IPO总和，这个领域何以爆发？

10月31日港股药品及生物科技行业沽空数据盘点，石药集团、康方生物、中国生物制药沽空金额位居行业前三

证券之星APP

京东健康与医疗器械企业“双向赋能”共建数字化健康新生态——走进鱼跃全球产业化基地

速递｜歌礼制药Amylin减肥新药向FDA申报！进入临床开发阶段

GLP1减重宝典

圣湘生物(688289.SH)四款产品取得医疗器械注册证

药明巨诺与再生元签署战略合作补充协议，携手加速TCR-T疗法开发

2025年西药行业市场发展现状趋势分析

2025 ESMO口头报告︱恒瑞创新药HRS-7058治疗KRAS G12C突变实体瘤I期研究结果发布

和誉医药2025研发日成功举办，展示创新管线布局与前沿临床进展

医药魔方Info

诺诚健华11月13日举行董事会会议考虑及批准第三季度业绩

每日卖空追踪 | 诺诚健华 10月31日卖空量成交151.5万股，卖空比例为10.07%

每日卖空追踪 | 亚盛医药-B 10月31日卖空量成交32.41万股，卖空比例为9.71%

每日卖空追踪 | 华领医药-B 10月31日卖空量成交13.3万股，卖空比例为3.66%

每日卖空追踪 | 科济药业-B 10月31日卖空量成交13.9万股，卖空比例为21.19%

每日卖空追踪 | 歌礼制药-B 10月31日卖空量成交30.4万股，卖空比例为8.11%

21个独家中成药火热！华润、国药领跑，云南白药暴涨396%，28款中药新药瞄准百亿市场

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK1574/news?page=2"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"生物医药B类股","latestPrice":618.7055,"timestamp":1761898110601,"preClose":605.53326,"halted":0,"volume":128593457,"delay":0,"changeRate":0.021753,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":13.172241,"latestTime":"10-31 16:00:00","open":605.58374,"high":627.6333,"low":600.08484,"amount":3826218301,"amplitude":0.045495,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1762133400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1761874200000,1761883200000],[1761886800000,1761897600000]],"pbRate":5.343409,"peRate":-44.036334,"turnoverRate":0.004666,"increases":23,"decrements":9,"flats":1,"marketCap":383100705664,"floatMarketCap":341050329040},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":627.6333,"amplitude":0.045495,"preClose":605.53326,"low":600.08484,"pbRate":"5.343409","latestPrice":618.7055,"volume":128593457,"delay":0,"open":605.58374,"prevYearClose":331.1933,"prevWeekClose":617.318,"prevMonthClose":618.706,"prevQuarterClose":752.859,"fiveDayClose":615.593,"twentyDayClose":752.859,"sixtyDayClose":779.344,"secType":"PLATE","market":"HK","turnoverRate":0.004666,"peRate":-44.036334,"marketCap":383100705664,"floatMarketCap":341050329040,"timestamp":1761898110601,"nameCN":"生物医药B类股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":23,"down":8,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2579469924","title":"创新药突然爆发，基金经理火线解读！多头猛攻，港股通创新药ETF（520880）大阳线拔地而起，放量摸高5.25%！","url":"https://stock-news.laohu8.com/highlight/detail?id=2579469924","media":"新浪基金","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579469924?lang=zh_cn&edition=fundamental","pubTime":"2025-10-31 19:53","pubTimestamp":1761911580,"startTime":"0","endTime":"0","summary":"10月最后一个交易日，沉寂已久的创新药板块突然大爆发，A港同频共振。重仓A股创新药的药ETF场内劲涨2.46%，三生国健20CM涨停。港股创新药尽显高弹性，100%创新药研发标的——港股通创新药ETF放量上探5.25%！业内人士指出，此举有望分流缓解高值创新药的支付压力。　　技术面看港股通创新药ETF，亮点颇多。　　港股通创新药ETF基金经理丰晨成最新表示，创新药行情可能随时再次启动，当下或是中长期维度配置创新药的高胜率区间。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2025-10-31/doc-infvuxsi8523212.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159992","BK1161","06978","BK1574","520880"],"gpt_icon":0},{"id":"2579463926","title":"归创通桥(02190)10月31日耗资约118.74万港元回购5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2579463926","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579463926?lang=zh_cn&edition=fundamental","pubTime":"2025-10-31 19:14","pubTimestamp":1761909296,"startTime":"0","endTime":"0","summary":"智通财经APP讯，归创通桥(02190)公布，2025年10月31日耗资约118.74万港元回购5万股股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1363821.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02190","BK1587","BK1100","BK1574","BK1583"],"gpt_icon":0},{"id":"2579633134","title":"迈博药业-B(02181)：张雁云已获指定为首席独立非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2579633134","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579633134?lang=zh_cn&edition=fundamental","pubTime":"2025-10-31 19:07","pubTimestamp":1761908823,"startTime":"0","endTime":"0","summary":"智通财经APP讯，迈博药业-B(02181)发布公告，自2025年10月31日起：执行董事钱卫珠博士已获委任为本公司提名委员会成员;执行董事陶静先生已不再担任提名委员会成员;及张雁云博士(本公司独立非执行董事(独董)、本公司薪酬委员会主席及提名委员会成员)已获指定为首席独立非执行董事(首席独董)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1363810.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02181","BK1574"],"gpt_icon":0},{"id":"2579468627","title":"歌礼制药-B(01672)10月31日耗资约193.27万港元回购20万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2579468627","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579468627?lang=zh_cn&edition=fundamental","pubTime":"2025-10-31 18:56","pubTimestamp":1761908168,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B(01672)公布，2025年10月31日耗资约193.27万港元回购20万股股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1363795.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","01672","BK1574","01477","BK1161","BK1191"],"gpt_icon":0},{"id":"2580249194","title":"9个月干了过去3年IPO总和，这个领域何以爆发？","url":"https://stock-news.laohu8.com/highlight/detail?id=2580249194","media":"和讯网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580249194?lang=zh_cn&edition=fundamental","pubTime":"2025-10-31 18:41","pubTimestamp":1761907267,"startTime":"0","endTime":"0","summary":"港股医疗保健行业通过IPO募资金额超过过去3年全年总和。仅9月以来，就有超12家药企向港交所递交IPO申请。截至2025年10月23日，港交所正在处理的上市申请约300家，其中半数为新经济领域企业，涵盖人工智能、生物技术等行业。这是2025年前十个月，中国创新药的大致表现。仅今年上半年，国家药品监督管理局批准创新药达40种，接近2024年全年总量。因为早期投入的企业得到了非常好的回报，这时中国创新药投融资开始爆发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025103118432394e75504&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025103118432394e75504&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1251922891.USD","BK1574","BK1583","LU0588546209.SGD","LU1719994722.HKD","LU1969619763.USD","BK1161","06160","BK1588","06978","LU1770034418.SGD","BK1500","LU1303224171.USD","LU2328871848.SGD","LU0307460666.USD"],"gpt_icon":0},{"id":"2580842321","title":"10月31日港股药品及生物科技行业沽空数据盘点，石药集团、康方生物、中国生物制药沽空金额位居行业前三","url":"https://stock-news.laohu8.com/highlight/detail?id=2580842321","media":"证券之星APP","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580842321?lang=zh_cn&edition=fundamental","pubTime":"2025-10-31 18:06","pubTimestamp":1761905164,"startTime":"0","endTime":"0","summary":"证券之星消息，10月31日港交所披露数据显示，当日港股药品及生物科技行业的158只个股中有70只被沽空，总沽空股数为1.76亿股，总沽空金额为29.03亿元（港元），而当日药品及生物科技行业的总成交金额为221.2亿元（港元），沽空比例为13.12%。从沽空金额来看，石药集团、康方生物、中国生物制药沽空金额位居行业前三，分别为4.46亿港元、3.36亿港元、2.51亿港元。沽空与卖空含义相同，即在并不持有股票的前提下，通过借入股票获得筹码进而卖出。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031181252974c1d4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031181252974c1d4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","LU0348825331.USD","LU1720050803.USD","IE00BZ08YS42.EUR","LU1807302812.USD","09926","LU1226288170.HKD","01093","LU1008478684.HKD","SG9999004220.SGD","LU0540923850.HKD","BK1589","IE00BZ08YT58.USD","01177","LU1993786604.SGD","BK1521","LU0417516738.SGD","LU1226288253.USD","LU0067412154.USD","LU2476274720.SGD","LU1152091168.USD","LU2039709279.SGD","LU2778985437.USD","IE00BPRC5H50.USD","LU0561508036.HKD","LU0417516902.SGD","IE0008368742.USD","LU0348784397.USD","LU1960683339.HKD","LU1328277881.USD","LU0140636845.USD","LU0348767384.USD","LU2399975544.HKD","LU0417516571.SGD","BK1574","LU0501845795.SGD","LU1226287529.USD","BK1161","LU0348827113.USD","LU2488822045.USD","IE00B031HY20.USD","LU0348766576.USD","LU0880133367.SGD","LU1794554557.SGD","LU2476274308.USD","LU0315179316.USD","LU0348783233.USD","LU1152091754.HKD","LU1951186391.HKD","LU1226287792.SGD"],"gpt_icon":0},{"id":"2579452089","title":"京东健康与医疗器械企业“双向赋能”共建数字化健康新生态——走进鱼跃全球产业化基地","url":"https://stock-news.laohu8.com/highlight/detail?id=2579452089","media":"动脉网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579452089?lang=zh_cn&edition=fundamental","pubTime":"2025-10-31 17:55","pubTimestamp":1761904500,"startTime":"0","endTime":"0","summary":"京东健康与鱼跃医疗在江苏丹阳的全球产业化基地展开深度合作，共建数字化健康新生态。京东健康通过其供应链网络，助力鱼跃医疗的智能医疗器械高效触达全国患者与家庭，实现从制造到终端的全链路服务。双方合作不仅是销售渠道的对接，更是基于数字化与供应链能力的深度共建。京东健康依托全国仓储物流体系，提升鱼跃产品流通效率，实现“当日达”“次日达”。同时，京东健康供应链管理系统与鱼跃制造体系高效协同，通过消费大数据动态调整布货计划，精准响应市场需求。此外，京东健康还助力鱼跃从“制造”转向“智造”，基于用户数据洞察推出具有房颤识别功能的电子血压计等创新产品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031180724a47fc569&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031180724a47fc569&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1222","LU0051755006.USD","SGXZ86797644.SGD","BK1589","09997","BK1100","BK1615","BK1574","BK1142","BK1591","BK1515","09996","BK1571","BK1247","LU0456827905.SGD","86618","06618","SGXZ62798434.SGD","BK1583"],"gpt_icon":0},{"id":"2580416212","title":"速递｜歌礼制药Amylin减肥新药向FDA申报！进入临床开发阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2580416212","media":"GLP1减重宝典","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580416212?lang=zh_cn&edition=fundamental","pubTime":"2025-10-31 17:53","pubTimestamp":1761904426,"startTime":"0","endTime":"0","summary":"整理 | GLP1减重宝典内容团队2025年10月30日，歌礼制药有限公司宣布，已选定一款有望成为同类最佳每月一次皮下注射胰淀素受体激动剂ASC36作为临床开发候选药物。歌礼预计将于2026年第二季度向美国食品药品监督管理局递交ASC36治疗肥胖症的新药临床试验申请。ASC36是利用歌礼基于结构的AI辅助药物发现和超长效药物开发平台技术自主研发的胰淀素受体激动剂多肽。每毫克多肽的减重效果更优，也可能使ASC36在规模化生产中成本更低。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031200933a47ffba9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031200933a47ffba9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","01477","BK1191","01672","BK1515"],"gpt_icon":0},{"id":"2579545244","title":"圣湘生物(688289.SH)四款产品取得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2579545244","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579545244?lang=zh_cn&edition=fundamental","pubTime":"2025-10-31 17:50","pubTimestamp":1761904233,"startTime":"0","endTime":"0","summary":"智通财经APP讯，圣湘生物 发布公告，公司的四款产品于近日收到由国家药品监督管理局颁发的《医疗器械注册证》，包括呼吸道合胞病毒核酸检测试剂盒、甲型流感病毒、乙型流感病毒、腺病毒核酸检测试剂盒、甲型流感病毒、乙型流感病毒、肺炎支原体核酸检测试剂盒和人鼻病毒、腺病毒、肺炎支原体核酸检测试剂盒。公司本次获证的四款产品均采用多重荧光PCR技术，具备高灵敏度、高特异性、操作简便等优势，最快可在30分钟内完成精准鉴别。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1363735.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","09996","BK1100","BK0239","159883","BK1222","09997","BK1583","688289"],"gpt_icon":0},{"id":"2579498056","title":"药明巨诺与再生元签署战略合作补充协议，携手加速TCR-T疗法开发","url":"https://stock-news.laohu8.com/highlight/detail?id=2579498056","media":"美通社","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579498056?lang=zh_cn&edition=fundamental","pubTime":"2025-10-31 17:40","pubTimestamp":1761903600,"startTime":"0","endTime":"0","summary":"通过本次补充协议，药明巨诺将获得最高可达5,000万美金的付款，包括MAGE-A4产品开发里程碑付款、药品生产流程监管里程碑付款、选择权行使费、慢病毒载体制造流程里程碑付款。根据补充协议，再生元将为药明巨诺的MAGE-A4靶点产品相关特定开发活动提供资金，于签署修订协议后向本公司支付首付款，并于达成补充协议所载特定开发里程碑事件时支付一系列一次性、不可退还的里程碑付款。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4812260_ZH12260_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["02126","BK1583","BK1574","BK1161"],"gpt_icon":0},{"id":"2579245144","title":"2025年西药行业市场发展现状趋势分析","url":"https://stock-news.laohu8.com/highlight/detail?id=2579245144","media":"中研网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579245144?lang=zh_cn&edition=fundamental","pubTime":"2025-10-31 17:39","pubTimestamp":1761903584,"startTime":"0","endTime":"0","summary":"2025年西药行业市场发展现状趋势分析在人口老龄化加速、医疗技术革新与政策红利的三重驱动下，中国西药行业正经历从“规模扩张”到“质量跃升”的关键转型。据中研产业研究院《2025-2030年中国西药行业竞争分析及发展前景预测报告》分析二、西药产业链及市场规模1. 上游：原料药国产化与CDMO崛起原料药是西药产业的基石。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031173949a47fb7a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031173949a47fb7a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU1046422090.SGD","06160","LU2125910500.SGD","09995","01177","BK1576","LU0708995583.HKD","LU2045819591.USD","02196","LU2242644610.SGD","BK1574","BK1583","01801","01276","09969","03692","LU0052750758.USD","02359","LU0320764599.SGD","SBHMY","01093","06978","BK1141"],"gpt_icon":0},{"id":"2580465445","title":"2025 ESMO口头报告︱恒瑞创新药HRS-7058治疗KRAS G12C突变实体瘤I期研究结果发布","url":"https://stock-news.laohu8.com/highlight/detail?id=2580465445","media":"恒瑞医药","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580465445?lang=zh_cn&edition=fundamental","pubTime":"2025-10-31 17:28","pubTimestamp":1761902907,"startTime":"0","endTime":"0","summary":"研究结果显示，HRS-7058在KRAS G12C突变晚期实体瘤中具有可控的安全性和有前景的抗肿瘤活性。KRAS G12C是KRAS突变的主要亚型之一。HRS-7058是恒瑞医药自主研发的一款新型口服KRAS G12C抑制剂，它能与KRAS G12C突变体的半胱氨酸发生不可逆结合，将该蛋白锁定在失活状态，从而阻断下游信号传导并发挥抗肿瘤作用。HRS-7058在CRC、PDAC以及KRAS G12C抑制剂经治NSCLC患者中，同样显示出治疗潜力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031175559a47fbfc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031175559a47fbfc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01276","BK1574","LU1023057109.AUD","BK1161","LU0359202008.SGD","LU0359201885.HKD","LU2543165471.USD","LU0359201612.USD","06978"],"gpt_icon":0},{"id":"2579346609","title":"和誉医药2025研发日成功举办，展示创新管线布局与前沿临床进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2579346609","media":"医药魔方Info","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579346609?lang=zh_cn&edition=fundamental","pubTime":"2025-10-31 17:17","pubTimestamp":1761902269,"startTime":"0","endTime":"0","summary":"2025年10月30日，和誉医药2025研发日在上海成功举办。本次活动以“和力聚梦 誉创未来”为主题，汇聚了数十家国内外投资机构代表、临床专家和媒体人士，与和誉医药管理层及研发团队共话公司创新研发布局和临床进展。ABSK043联合其他药物用于晚期NSCLC和胃癌一线治疗的II期临床研究正在进行中。通过此次研发日活动，和誉医药全面展示了其创新研发实力与前沿临床进展，彰显公司在肿瘤及其他领域持续拓展产品管线的战略决心。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031180912a47fc65e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031180912a47fc65e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK1574","09939","BK1161","02256","BK1515"],"gpt_icon":0},{"id":"2580415605","title":"诺诚健华11月13日举行董事会会议考虑及批准第三季度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2580415605","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580415605?lang=zh_cn&edition=fundamental","pubTime":"2025-10-31 16:39","pubTimestamp":1761899952,"startTime":"0","endTime":"0","summary":"格隆汇10月31日丨诺诚健华(09969.HK)宣布，公司将于2025年11月13日(星期四)举行董事会会议，藉以(其中包括)考虑及批准公司及其附属公司截至2025年9月30日止九个月之未经审核第三季度业绩及其发布。财经频道更多独家策划、专家专栏，免费查阅>>责任编辑：钟离","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031164313a47f99df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031164313a47f99df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","09969","BK1161"],"gpt_icon":0},{"id":"2580141561","title":"每日卖空追踪 | 诺诚健华 10月31日卖空量成交151.5万股，卖空比例为10.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580141561","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580141561?lang=zh_cn&edition=fundamental","pubTime":"2025-10-31 16:30","pubTimestamp":1761899437,"startTime":"0","endTime":"0","summary":"诺诚健华北京时间10月31日，涨3.34%，卖空量成交151.5万股，较上一交易日减少15.97%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031163550a47f94f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031163550a47f94f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09969","BK1161","BK1574"],"gpt_icon":0},{"id":"2580644867","title":"每日卖空追踪 | 亚盛医药-B 10月31日卖空量成交32.41万股，卖空比例为9.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580644867","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580644867?lang=zh_cn&edition=fundamental","pubTime":"2025-10-31 16:30","pubTimestamp":1761899432,"startTime":"0","endTime":"0","summary":"亚盛医药-B北京时间10月31日，涨2.31%，卖空量成交32.41万股，较上一交易日增加29.23%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031163511a6d87c00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031163511a6d87c00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06855","BK1574","BK1161"],"gpt_icon":0},{"id":"2580853449","title":"每日卖空追踪 | 华领医药-B 10月31日卖空量成交13.3万股，卖空比例为3.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580853449","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580853449?lang=zh_cn&edition=fundamental","pubTime":"2025-10-31 16:30","pubTimestamp":1761899428,"startTime":"0","endTime":"0","summary":"华领医药-B北京时间10月31日，涨0.57%，卖空量成交13.3万股，较上一交易日减少34.16%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031163444974bf2a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031163444974bf2a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02552","BK1574"],"gpt_icon":0},{"id":"2579467085","title":"每日卖空追踪 | 科济药业-B 10月31日卖空量成交13.9万股，卖空比例为21.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579467085","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579467085?lang=zh_cn&edition=fundamental","pubTime":"2025-10-31 16:30","pubTimestamp":1761899425,"startTime":"0","endTime":"0","summary":"科济药业-B北京时间10月31日，涨1.17%，卖空量成交13.9万股，较上一交易日减少69.91%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025103116340794e71fd1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025103116340794e71fd1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1585","BK1587","BK1574","02171","BK1161"],"gpt_icon":0},{"id":"2580416754","title":"每日卖空追踪 | 歌礼制药-B 10月31日卖空量成交30.4万股，卖空比例为8.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580416754","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580416754?lang=zh_cn&edition=fundamental","pubTime":"2025-10-31 16:30","pubTimestamp":1761899421,"startTime":"0","endTime":"0","summary":"歌礼制药-B北京时间10月31日，涨3.65%，卖空量成交30.4万股，较上一交易日减少25.31%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031163323974bf1f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031163323974bf1f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1574","BK1191","BK1161","01672","01477"],"gpt_icon":0},{"id":"2580241681","title":"21个独家中成药火热！华润、国药领跑，云南白药暴涨396%，28款中药新药瞄准百亿市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2580241681","media":"米内网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580241681?lang=zh_cn&edition=fundamental","pubTime":"2025-10-31 16:24","pubTimestamp":1761899043,"startTime":"0","endTime":"0","summary":"TOP7品牌2025H1销售额均超过3000万元。11个品牌销售额涨幅达两位数及以上，其中，贵州弘泽制药的制酸止痛胶囊暴涨3387.32%、云南白药的参苓健脾胃颗粒暴涨1326.27%、沈阳绿洲制药的固本益肠片暴涨147.71%、未来药物的雪山胃宝丸大涨90.55%、上海黄海制药的扶正化瘀胶囊大涨82%。2025H1该产品销售额暴涨3387.32%至超2000万元，跻身消化系统疾病中成药品牌榜单前列，排在第十三位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031163913a47f9773&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031163913a47f9773&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2088748376.SGD","BK1191","LU1008478684.HKD","IE0008368742.USD","LU0650527681.SGD","LU0594300419.USD","LU0359202008.SGD","LU1366334651.USD","SG9999009997.SGD","01477","LU2088747725.USD","LU0516423091.SGD","BK1570","LU0417516902.SGD","BK1555","LU1152091168.USD","LU1242518857.USD","LU2088748020.USD","LU0348825331.USD","LU1242518931.SGD","BK1521","LU0501845795.SGD","LU1993786604.SGD","LU1960683339.HKD","LU2088748293.HKD","LU0516422952.EUR","SG9999014674.SGD","LU0594300179.USD","LU0738912210.USD","SG9999010052.SGD","LU0880133367.SGD","LU0370786039.SGD","LU0516422366.SGD","LU0605514214.HKD","LU0251144936.SGD","BK1589","LU0072913022.USD","LU1366334578.USD","BK1574","LU0414403682.SGD","LU0979878070.USD","LU2088747998.USD","LU0067412154.USD","BK1240","LU0791591158.USD","SG9999010078.USD","01109","LU1880383366.USD","LU0173614495.USD","LU0287142896.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":30,"pageCount":2,"totalSize":586,"code":"91000000","status":"200"}]}}